Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bright Minds Biosciences | CSE | Healthcare | Biotechnology & Medical Research | $399.12M | -60.4x | -1.69 | $57.44 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.6% Upside | Upgrade to Pro+ | |
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | $263.67M | -1.8x | -0.14 | $13.14 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fennec Pharma | Toronto | Healthcare | Biotechnology & Medical Research | $245.78M | -148.7x | -1.59 | $8.93 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | $222.17M | -6.8x | 0.83 | $3.16 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.4% Upside | Upgrade to Pro+ | |
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | $159.95M | -3.5x | -0.17 | $4.49 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $154.23M | -3.5x | 0.19 | $1.89 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | $146.73M | -12.7x | -1.07 | $1.41 | 15.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | $135.21M | -5.1x | 0.04 | $1.73 | -7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | $110.22M | -3.7x | -0.14 | $1.43 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | $100.16M | -3.4x | 0.17 | $0.88 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.2% Upside | Upgrade to Pro+ | |
ME Therapeutics Holdings | CSE | Healthcare | Biotechnology & Medical Research | $70.90M | $3 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | $63.20M | -1.6x | 0.47 | $0.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | $63M | -372.5x | -2.7 | $1.22 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | $55.59M | 15.8x | 0 | $0.41 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | $50.36M | -6.6x | 0.05 | $0.28 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | $48.21M | -7.2x | -0.37 | $0.68 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $47.55M | -4.8x | 0.13 | $0.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | $36.37M | -4.5x | -0.1 | $0.33 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $34.48M | -0.6x | -0.03 | $0.78 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $30.57M | 0.06 | $0.64 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $30.57M | 0.06 | $0.64 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sona Nanotech | CSE | Healthcare | Biotechnology & Medical Research | $27.37M | -8.1x | 0.05 | $0.25 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $26.85M | -7x | 4 | $0.59 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmala Biotech Holdings | CSE | Healthcare | Biotechnology & Medical Research | $19.99M | $0.23 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Biovaxys Technology | CSE | Healthcare | Biotechnology & Medical Research | $18.94M | -0.06 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sirona Biochem Corp | TSXV | Healthcare | Biotechnology & Medical Research | $17.14M | -6.5x | 0.46 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | $15.59M | -9.1x | 0.28 | $0.20 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rakovina Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $15.35M | -2.2x | 0.37 | $0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Resverlogix Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $14.03M | -0.9x | -0.06 | $0.05 | -18.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $13.82M | -0.6x | 0.09 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |